Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber

You are using software which is blocking our advertisements (adblocker).

As we provide the news for free, we are relying on revenues from our banners. So please disable your adblocker and reload the page to continue using this site.
Thanks!

Click here for a guide on disabling your adblocker.

Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber

India: ICAR and Bayer sign MoU for bioefficacy trials on roses

The ICAR-Directorate of Floricultural Research, Pune, has entered into a Memorandum of Understanding (MoU) with Bayer Crop Science Ltd. to undertake collaborative contract research on pesticide bioefficacy in rose cultivation.

The MoU formalizes a joint project titled "Evaluating the Toxicity of Spidoxamat 36 g/L + Abamectin 18 g/L OD Formulation Against Thrips and Mites Infesting Roses Under Open Field Conditions."

The agreement was signed by Dr. K. V. Prasad, Director, ICAR-DFR, and Dr. Prafull Malthankar and Dr. Sangram Waghchaure representing Bayer Crop Science Ltd.

© ICAR-Directorate of Floricultural Research, Pune

Under the terms of the agreement, ICAR-DFR will conduct a two-year open-field study to assess the effectiveness of the Spidoxamat + Abamectin formulation in controlling key rose pests, particularly thrips and mites. The study will also evaluate the potential impact of the formulation on beneficial natural enemies within the rose agroecosystem.

This collaboration is expected to contribute valuable scientific insights into sustainable pest management strategies for floriculture, with a focus on improving crop health and productivity while preserving ecological balance.

For more information:
Bayer

www.bayer.com

Indian Council of Agricultural Research
www.icar.org.in/

Publication date:

Related Articles → See More